Guo-Liang Yu, Ph.D.
Co-Founder, Executive Director, Chairman and Chief Executive Officer
Biography
Dr. Guo-Liang Yu is currently the Executive Chairman of Crown Bioscience Inc., a personalized oncology platform company with 400 employees globally. Dr. Yu co-founded Epitomics Inc., an antibody biotechnology company recently acquired by Abcam at $170 M. He served as Chairman, President and CEO of Epitomics Inc. for 10 years.
